Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. human health improvement
Show results for
Products
Services
Training

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • This Year
  • Older

Human Health Improvement Articles & Analysis

55 news found

Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

Creative Diagnostics Expands Hepatitis B Research Tools with High Performance HBV Surface Antigen L-Proteins

Hepatitis B virus (HBV) is a species of the genus Orthohepatovirus, which also belongs to the family Hepatoviridae. HBV is known to infect only humans and primates, causing hepatitis B. In 1965, Dana discovered the hepatitis B virus. ...

ByCreative Diagnostics


CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service

CD Genomics Unveils A Pioneering Genomics Approach—Long Amplicon Analysis (LAA) Service

CD Genomics, a trailblazing genomics and bioinformatics services provider, is delighted to announce the launch of the Long Amplicon Analysis (LAA) service, a mature genomic research method that promises to revolutionize the field. With LAA, scientists can now explore intricate genomic landscapes, facilitating groundbreaking discoveries and advancements in various branches of genomics. Long ...

ByCD Genomics


EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain

EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain

EMOTIV, the bioinformatics pioneer advancing understanding of the human brain using electroencephalography (EEG), today added two renowned scientists to its executive leadership team, naming Dr. ...

ByEmotiv Inc.


How to deal with the trend of population aging to achieve a sustainable future

How to deal with the trend of population aging to achieve a sustainable future

People are living longer due to improved health and medical care, increased access to education and lower fertility rates. ...

ByShenzhen Yujiaxin Tech Co., Ltd


Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

Microbiome research has rapidly gained momentum in recent years as scientists have come to appreciate the vital role that microbial communities play in maintaining human health. However, analyzing the vast amounts of data generated by high-throughput sequencing of microbiome samples can be a daunting task. ...

ByCD Genomics


BMG LABTECH and InvivoSciences, Inc. Initiate Market Collaboration To Accelerate Drug Discovery in Engineered 3D Tissues

BMG LABTECH and InvivoSciences, Inc. Initiate Market Collaboration To Accelerate Drug Discovery in Engineered 3D Tissues

Employing an automated system, 3D heart tissues are fabricated with cardiomyocytes derived from human induced pluripotent stem cells. The ultra- sensitive plate reader, CLARIOstar®, will analyze rapid beat-to-beat changes (up to 50 Hz) in the fluorescence intensities of dyes that indicate physiological states in engineered 3D heart tissue after drug/compound application. ...

ByInvivoSciences, Inc. (IVS)


History of Health Technologies and Meaningful Change in the Era of Health 4.0

History of Health Technologies and Meaningful Change in the Era of Health 4.0

Dr. Ali Tinazli's post at the Forbes magazine about "History Of Health Technologies And Meaningful Change In The Era Of Health 4.0" The medicine in ancient Egypt is some of the oldest in history. Although rudimentary, it was already highly personalized and with exclusive access. During the Renaissance—one of the most remarkable ages of humankind—medicine ...

ByLifespin GmbH


Sage Therapeutics and Biogen Present Further Analyses from Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression at the European College of Neuropsychopharmacology (ECNP) Congress

Sage Therapeutics and Biogen Present Further Analyses from Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression at the European College of Neuropsychopharmacology (ECNP) Congress

Treatment with zuranolone was shown to significantly improve symptoms of anxiety at Days 3, 8, 15, and 45 (p less than 0.05, at all time points) when compared to placebo as measured by the Hamilton Anxiety Rating Scale (HAM-A). ...

BySage Therapeutics


Sage Therapeutics and Biogen to Host Investor Webcast on December 6, 2022 to Discuss Potential Commercialization Plans for Zuranolone

Sage Therapeutics and Biogen to Host Investor Webcast on December 6, 2022 to Discuss Potential Commercialization Plans for Zuranolone

About Sage Therapeutics Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. ...

BySage Therapeutics


Radiopharm Theranostics signs agreement with ANSTO for the supply of key isotope lutetium-177

Radiopharm Theranostics signs agreement with ANSTO for the supply of key isotope lutetium-177

"ANSTO is committed to work that improves human health and saves lives through technologies for diagnostic, therapeutic and innovative treatments for current and emerging diseases," said Shaun Jenkinson, CEO of ANSTO. ...

ByRadiopharm Theranostics


Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin

Synbiotic Health Announces the Expansion of their R&D and Commercial Capabilities with the Acquisition of a New Facility in Madison, Wisconsin

The new facility is dedicated to the development and commercialization of advanced probiotic ingredients for improved health. The Madison facility, which is scheduled to come online in early 2023, will focus on scale-up and development of efficient commercial processes. ...

BySynbiotic Health


FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

FDA Approves Taiho’s LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

“This approval is an important milestone for patients and may provide hope for improved outcomes. As someone whose family has been impacted by cholangiocarcinoma, I’m acutely aware of the impact this disease can have on the patient and their loved ...

ByTaiho Oncology, Inc.


Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone

Sage Therapeutics and Biogen Present New Analyses at Psych Congress Further Evaluating the Efficacy and Safety of Zuranolone

Data from a post-hoc analysis of 4 studies in the LANDSCAPE program demonstrated that improvements in depressive symptoms with zuranolone at Day 15 were sustained beyond the end of treatment. ...

BySage Therapeutics


Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

Drug Combination Meets Survival Endpoint in Phase III Pivotal Trial Involving Participants With Refractory Metastatic Colorectal Cancer

Results from the primary analysis of the SUNLIGHT trial to be presented at an upcoming scientific conference Paris - September 12, 2022– Servier, Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., announced today that the investigational combination of trifluridine/tipiracil plus bevacizumab showed a statistically significant improvement in the primary endpoint of ...

ByTaiho Oncology, Inc.


Celdara Medical Announces Funding for Alzheimer’s-Focused Fellowship Opportunities

Celdara Medical Announces Funding for Alzheimer’s-Focused Fellowship Opportunities

” Blessing Akobundu, another recent Fellow, adds, “The Fellowship program at Celdara is a great opportunity to learn about and actively engage in identifying exciting and innovative research with the potential of improving human health.” Speaking on the combination of research and entrepreneurial training, she notes that, ...

ByCeldara Medical, LLC


Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl

Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl

Our corporate philosophy is simple: “We strive to improve human health and contribute to a society enriched by smiles.” For more information about Taiho Pharmaceutical Co., Ltd., please visit: https://www.taiho.co.jp/en/ Forward Looking Statements This press release contains forward-looking statements within the meaning of The ...

ByTaiho Oncology, Inc.


U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Taiho Oncology’s New Drug Application for Futibatinib for Cholangiocarcinoma

The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. ...

ByTaiho Oncology, Inc.


CD Genomics MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development

CD Genomics MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development

With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics solutions, which hold promise in uncovering novel ways to treat disease and improve human health. The transcriptome is the complete set of RNAs encoded by an organism's genome. ...

ByCD Genomics


DRIVEN Alumni Surpass $50M in Follow-on Funding

DRIVEN Alumni Surpass $50M in Follow-on Funding

Led by Celdara Medical and Simbex, it has always had a singular goal: improve human health by increasing the number, quality, and success rate of biomedical startups. ...

ByCeldara Medical, LLC


Kallyope Raises $236M Series D Financing to Fuel Expansion of Novel Gut-Brain Axis Therapeutic Programs

Kallyope Raises $236M Series D Financing to Fuel Expansion of Novel Gut-Brain Axis Therapeutic Programs

The gastrointestinal tract is the largest and most accessible drug target in the human body. By revealing the connections between the gut and the brain, the Kallyope platform has been leveraged to generate novel programs spanning several relevant therapeutic areas, including metabolism, immunology and inflammation, and central nervous system disorders. ...

ByKallyope Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT